Cancer-Related Dictionary

A T-cell, also known as a T-lymphocyte, is a type of white blood cell that plays a fundamental role in the immune system. T-cells primarily perform the role of identifying and destroying abnormal or infected cells, including bacteria and viruses, to protect the body from infection or disease. They also aid in stimulating other immune responses. The 'T' stands for thymus, the gland in which these cells mature.

Testicular cancer is a type of malignancy that originates in the testicles, which are male reproductive organs producing sperm and hormones. This condition, while rare compared to other cancers, is the most common cancer in American men aged 15-35. It's highly treatable, often curable, but early detection is crucial for better prognosis and recovery.

Thymic carcinoma is a rare type of cancer that originates in the thymus gland, located in the upper chest. Unlike thymomas, which are typically benign, thymic carcinomas are malignant and can spread to other parts of the body.

A thyroid lobectomy is a surgical procedure where one lobe (half) of the thyroid gland is removed. This is often done when there is a suspicious nodule or tumor, or for treating certain thyroid conditions.

Thyroid cancer is a type of malignancy that begins in the thyroid gland, a butterfly-shaped organ at the base of the throat responsible for hormone production. Symptoms often include a lump in the neck, voice changes, difficulty swallowing, or unexplained weight changes. Treatment depends on the stage and type of cancer but can include surgery, radioactive iodine therapy, hormonal therapy, and chemotherapy. Early detection allows for a high survival rate.

Tissue microarrays are a laboratory technique used to analyze multiple tissue samples simultaneously on a single slide. This method allows researchers to study the expression of proteins or genes in various tissues efficiently, making it a valuable tool in cancer research and pathology.

Tomotherapy is a unique type of radiation therapy used in cancer treatment. It combines the precision of 3D imaging with rotational delivery of radiation, precisely targeting the tumor from all angles. This technique helps to minimize exposure to healthy tissue, thereby reducing side effects. Tomotherapy offers the advantage of adjusting doses to match a tumor’s size, shape and location.

Topoisomerase inhibitors are medications that interfere with the action of topoisomerase enzymes, which help manage the structure of DNA during cell division. These inhibitors are primarily used in cancer treatment to prevent cancer cells from proliferating.

"Transition" refers to the process or period of changing from one state, condition, or place to another. It can relate to personal developments, such as life transitions, or wider societal changes. It can also pertain to the movement in writing or speech from one point or topic to another, ensuring logical coherence and flow.

Transoral robotic surgery is a minimally invasive surgical technique that uses robotic systems to remove tumors or perform procedures in the mouth and throat through the mouth, without external incisions.

Triple-negative breast cancer (TNBC) refers to a subtype of breast cancer characterized by the absence of estrogen, progesterone, and HER2 receptors, making it less responsive to hormonal therapies. This type of cancer is often more aggressive and has a higher risk of recurrence compared to other types, requiring specialized treatment strategies.

A tumor refers to a mass or lump of abnormal cells in the body which can be benign (non-cancerous), pre-malignant (pre-cancerous), or malignant (cancerous). Tumors can occur anywhere in the body and may grow slowly or rapidly. They may cause symptoms due to their size or location, or can be asymptomatic. Tumors are generally diagnosed through imaging tests, biopsies, and other medical examinations.

A tumor board is a group of medical experts from various specialties who collaborate to discuss and plan the best treatment approach for patients with complex cancer cases. This multidisciplinary team typically includes oncologists, radiologists, pathologists, surgeons, and other healthcare professionals.

Tumor burden refers to the total amount of cancer present in a person's body. It includes the size of the tumor, the number of cancerous cells, and the extent to which cancer has spread to other parts of the body.

Tumor progression refers to the process by which a tumor grows and potentially becomes more aggressive, spreading to other parts of the body. This involves changes at the cellular level, where cancer cells divide uncontrollably, invade nearby tissues, and may metastasize to distant organs.

Tumor vasculature refers to the network of blood vessels that supply nutrients and oxygen to a tumor, enabling its growth and survival. This vascular system is often abnormal compared to normal tissue vasculature, with irregular structure and function.

Tumor markers are substances, often proteins, found in blood, urine, and tissue, produced by cancerous cells or by the body in response to cancer. They are valuable as they can indicate the presence, type, and progression of a malignancy. However, these markers are not entirely specific to cancer and can be elevated in non-cancerous conditions.

Tumor suppressor genes are a type of gene that makes a protein called a tumor suppressor protein, which helps regulate cell division. These genes primarily function to prevent cells from growing and dividing too rapidly or in an uncontrolled way, playing a vital role in preventing cancer. Mutations or abnormalities in these genes could lead to uncontrolled cell growth, leading to cancer.

Tumor-infiltrating lymphocytes (TILs) are immune cells that have moved from the bloodstream into a tumor. They are part of the body's natural defense system and can recognize and attack cancer cells, which can help in slowing down or stopping tumor growth.